Back
Bio-Rad Laboratories Quote, Financials, Valuation and Earnings
Sponsored
BIO
Sponsored
Election Shock on August 19th?
Click here now to see the evidence I've gathered.
Sell
27
BIO
Bio-Rad Laboratories
Last Price:
275.89
Seasonality Move:
5.57%
7 Day Trial
ALL ACCESS PASS
$
7
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the cornerBio-Rad Laboratories Price Quote
$275.89
-0.05 (0.11%)
(Updated: April 27, 2024 at 5:55 AM ET)
Bio-Rad Laboratories Key Stats
Sell
27
Bio-Rad Laboratories (BIO)
is a Sell
Day range:
$274.91 - $279.77
52-week range:
$261.59 - $473.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.02
P/B ratio:
0.9%
Volume:
179.2K
Avg. volume:
198K
1-year change:
-36.71%
Market cap:
$7.9B
Revenue:
$2.7B
EPS:
$-21.49
How Much Does Bio-Rad Laboratories Make?
-
How Much Are Bio-Rad Laboratories's Sales Annually?
BIO Revenues are $2.7B -
How Much Profit Does Bio-Rad Laboratories's Make A Year?
BIO net income is -$637.3M
Is Bio-Rad Laboratories Growing As A Company?
-
What Is Bio-Rad Laboratories's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.07% -
What Is Bio-Rad Laboratories's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.56%
Bio-Rad Laboratories Stock Price Performance
-
Did Bio-Rad Laboratories Stock Go Up Last Month?
Bio-Rad Laboratories share price went down by -18.97% last month -
Did BIO's Share Price Rise Over The Last Year?
BIO share price fell by -36.71% over the past 1 year
What Is Bio-Rad Laboratories 52-Week High & Low?
-
What Is Bio-Rad Laboratories’s 52-Week High Share Price?
Bio-Rad Laboratories has traded as high as $473.50 over the past 52 weeks -
What Is Bio-Rad Laboratories’s 52-Week Low Share Price?
Bio-Rad Laboratories has traded as low as $261.59 over the past 52 weeks
Bio-Rad Laboratories Price To Free Cash Flow
-
Is Bio-Rad Laboratories Stock Overvalued?
Bio-Rad Laboratories is trading at a price to free cash flow ratio of 37.02 -
Is Bio-Rad Laboratories Stock Undervalued?
Bio-Rad Laboratories EV to Free Cash Flow ratio is 34.19 -
What Is Bio-Rad Laboratories’s Price Earnings Growth Ratio?
BIO PEG ratio is 0.00 -
Is Bio-Rad Laboratories Trading At A Premium To Earnings?
Bio-Rad Laboratories EV to EBIT ratio is 0.00
Is It Risky To Buy Bio-Rad Laboratories?
-
How Much Debt Does Bio-Rad Laboratories Have?
Total long term debt quarterly is $1.2B -
How Much Cash Does Bio-Rad Laboratories Have?
Cash and short term investments quarterly total is $1.6B -
What Is Bio-Rad Laboratories’s Book Value Per Share?
Book value per share is 306.51
Is Bio-Rad Laboratories Cash Flow Positive?
-
What Is BIO Cash Flow From Operations?
Cash flow from operations (TTM) is $374.9M -
What Is Bio-Rad Laboratories’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$425.6M -
What Is Bio-Rad Laboratories’s Cash Flow From Investing?
Cash flow from investing (TTM) is $20.2M
Bio-Rad Laboratories Return On Invested Capital
-
Is Management Doing A Good Job?
BIO return on invested capital is -6.25% -
What Is Bio-Rad Laboratories Return On Assets?
ROA measures how assets are converting to revenues and is -5.03% -
What Is BIO Return On Equity?
ROE is a measure of profitability and is -7.08%
Bio-Rad Laboratories Earnings Date & Stock Price
-
What Is Bio-Rad Laboratories's Stock Price Today?
A single share of BIO can be purchased today for 275.94 -
What Is Bio-Rad Laboratories’s Stock Symbol?
Bio-Rad Laboratories trades on the nyse under the ticker symbol: BIO -
When Is Bio-Rad Laboratories’s Next Earnings Date?
The next quarterly earnings date for Bio-Rad Laboratories is scheduled on May 7, 2024 -
When Is BIO's next ex-dividend date?
Bio-Rad Laboratories's next ex-dividend date is May 26, 2020 -
How To Buy Bio-Rad Laboratories Stock?
You can buy Bio-Rad Laboratories shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Bio-Rad Laboratories Competitors
-
Who Are Bio-Rad Laboratories's Competitors?
Below is a list of companies who compete with Bio-Rad Laboratories or are related in some way:
Bio-Rad Laboratories Dividend Yield
Data Unavailable
Bio-Rad Laboratories Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -56.3% | 8.16% |
Revenue: | -6.72% | -0.79% |
Analyst Recommendations
Buy Recommendations: | 4 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 428.90 |
Upside from Last Price: | 55.43% |